Schering-Plough to buy Akzo's Organon for $14.5 bln (Reuters via Yahoo! News)
Akzo Nobel said on Monday it was selling its drugs unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offering.

Schering to buy Dutch drug unit (The Record)
Schering-Plough Corp. said Monday it will buy the pharmaceutical division of Netherlands-based health care products maker Akzo Nobel NV for $14.4 billion in cash, in a bid to diversify its product range and strengthen its pipeline of new drugs.

Schering-Plough to buy Akzo's Organon for $14.4 bln (Reuters via Yahoo! News)
Schering-Plough Corp has agreed to buy Akzo Nobel NV's drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.